Arno Motulsky

PXL 20220914 181416412.MP

Arno Motulsky (July 5, 1923 – January 17, 2018) was a pioneering figure in the fields of genetic medicine and pharmacogenomics, whose work has had a profound impact on the understanding of genetics and its application to medicine. Born in Germany, Motulsky's early life was marked by the challenges of fleeing Nazi persecution, which ultimately led him to the United States where he embarked on a career that would make significant contributions to medical science.

Early Life and Education

Arno Motulsky was born in Fischhausen, East Prussia (now Primorsk, Russia). In 1939, he and his family fled Nazi Germany, arriving in the United States in 1941. Motulsky's experiences during his formative years would later influence his interest in the genetic basis of disease. He pursued his education in the United States, earning a B.S. from the University of Illinois in 1947, followed by an M.D. from the University of Kentucky in 1953.

Career and Contributions

After completing his medical degree, Motulsky's interest in genetics led him to join the faculty at the University of Washington in 1957, where he would remain for the duration of his career. He is credited with founding the Division of Medical Genetics in the Department of Medicine at the University of Washington, one of the first of its kind in the world.

Motulsky's research spanned several key areas in genetics and medicine. He was a pioneer in the field of pharmacogenomics, studying how genetic variation affects individual responses to drugs. His work in this area laid the groundwork for the development of personalized medicine, where treatments can be tailored to the genetic makeup of individual patients.

In addition to pharmacogenomics, Motulsky made significant contributions to our understanding of the genetic basis of diseases such as hemophilia, thalassemia, and G6PD deficiency. His research also extended into the study of genetic factors influencing complex traits such as blood pressure and cholesterol levels, contributing to the field of complex trait genetics.

Motulsky was also known for his work on the ethical, legal, and social implications of genetic research. He advocated for the responsible use of genetic information and technology, emphasizing the importance of considering the broader societal impacts of genetic advancements.

Legacy

Arno Motulsky's contributions to medical genetics and pharmacogenomics have left a lasting legacy. He authored over 400 scientific papers and was a mentor to numerous students and researchers in the field. His work has been recognized with numerous awards and honors, reflecting his status as a leading figure in genetic medicine.

Motulsky's pioneering research has paved the way for advances in personalized medicine and our understanding of the genetic basis of disease. His commitment to the ethical implications of genetic research continues to influence discussions in the field.

Selected Publications

• Genetic and Evolutionary Aspects of Blood Groups (1960)
• Pharmacogenetics and Ecogenetics in the Prevention of Drug-Related Toxicity (1977)
• Human Genetics: Problems and Approaches (co-authored with Friedrich Vogel, first published in 1979)

Awards and Honors

• Member of the National Academy of Sciences
• Member of the American Academy of Arts and Sciences
• Recipient of the Allan Award from the American Society of Human Genetics

Death

Arno Motulsky passed away on January 17, 2018, leaving behind a rich legacy in the fields of genetic medicine and pharmacogenomics. His work continues to influence current research and the development of new approaches to treatment and prevention of genetic diseases.